Plain-English translation of NCT06966453 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a new drug called for people with advanced breast cancer (cancer that has spread beyond the breast). The medication is given as an infusion directly into your vein every two weeks. Researchers want to learn whether this treatment is safe and whether it helps slow or stop the growth of cancer cells.
Many people with advanced breast cancer need new treatment options, especially when existing therapies stop working or cause too many side effects. This medication is designed to target cancer cells in a new way, and this trial aims to see if it offers hope for patients who have limited options.
You would receive the medication as an IV infusion at the study clinic once every two weeks for as long as you and your doctor believe it is helping and you can tolerate it. During treatment, you'll have study visits every two weeks to check your health and see how your cancer is responding. After you stop the medication, you'll have follow-up visits about every 6 weeks, then phone calls about every 12 weeks, so the research team can continue monitoring how you're doing.
AI-generated summary from trial data · Sep 19, 2026 · Not medical advice
United States